Trisiloxane, 1,3,5-tris(2,2-diphenylethyl)-1,1,3,5,5-pentamethyl- (820207-15-6)

Other Product

• Trisiloxane,3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-1-hexyl-1,1,3,5,5-pentamethyl-5-octyl-
• Trisiloxane,1,1,3,3,5,5-hexamethyl-1-[2-(7-oxabicyclo[4.1.0]hept-3-yl)ethyl]-5-[2-(trimethoxysilyl)ethyl]-
• 2-Pyrrolidinone, 1-(2,2-diphenylethyl)-5-ethoxy-
• Piperidine,1-[2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl]-, hydrochloride (1:1)
• 2-Propanol,1-[(1,2-diphenylethyl)amino]-3-[5-methyl-2-(1-methylethyl)phenoxy]-,hydrochloride
• 1,1':3',1''-Terphenyl, 2'-methoxy-3,3'',5,5',5''-pentamethyl-
• [1,1':3',1''-Terphenyl]-2'-ol, 3,3'',5,5',5''-pentamethyl-
• 1-Hexanol, 2-ethyl-, reaction products with 3-methyl-1,1,1,5,5,5-hexakis(1-methylpropoxy)-3-((tris(1-methylpropoxy)silyl)oxy)trisiloxane
• Piperidine,1-[2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl]-
• 3-Pyrrolidinamine,N-[[5-(4-chlorophenyl)-2-furanyl]methyl]-1-(2,2-diphenylethyl)-,bis(trifluoroacetate)
• o-(p-hydroxybenzoyl)benzoic acid, compound with 1-[2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl]piperidine (1:1)
• Trisiloxane, 1,5-dibutyl-1-ethoxy-1,3,3,5,5-pentamethyl-
• Piperazine,1-[2,3-dihydro-2,2,4,6,7-pentamethyl-3-(1-pyrrolidinyl)-5-benzofuranyl]-4-[2-(3-methoxyphenyl)ethyl]-
• 3-Isoxazolemethanol,5-[2-(2,3-dihydro-1,1,2,3,3-pentamethyl-1H-inden-5-yl)-1-propenyl]-,(E)-
• 3-Isoxazolecarboxylic acid,5-[2-(2,3-dihydro-1,1,2,3,3-pentamethyl-1H-inden-5-yl)-1-propenyl]-,(E)-
• 3-Isoxazolecarboxamide,5-[2-(2,3-dihydro-1,1,2,3,3-pentamethyl-1H-inden-5-yl)-1-propenyl]-,(E)-
• 3-Thiophenecarboxylicacid,5-[(1E)-2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propen-1-yl]-
• Trisiloxane,3-chloro-1,1,1,5,5,5-hexakis(1-methylpropoxy)-3-[[tris(1-methylpropoxy)silyl]oxy]-
• 5-Benzofuranol,2,3-dihydro-2,2,4,6,7-pentamethyl-3-[(4-methyl-1-piperazinyl)methyl]-,hydrochloride (1:2)
• Piperazine,1-[2,3-dihydro-2,2,4,6,7-pentamethyl-3-(1-pyrrolidinyl)-5-benzofuranyl]-4-(2-phenylethyl)-